Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
11/21/2024
CStone and Pharmalink Enter into Strategic Partnership for Sugemalimab...
11/21/2024
Merck's Belzutifan Approved in China for VHL Disease-Associated Tumors
11/21/2024
RDPAC Reinforces Strategic Commitment to China's Pharmaceutical Market
11/21/2024
Sino Biopharma Strengthens Oncology Portfolio with Investment in LaNov...
11/20/2024
FDA Issues Warning to Tianjin Darentang for Manufacturing and Transpar...
11/20/2024
J&J and Merck Restructure Operations in China Amid Market Challenges
11/20/2024
Probe of AstraZeneca Executive in China Raises Questions About Company...
11/20/2024
Promoting Collaboration in Regional Healthcare Systems in Hong Kong, ...
11/19/2024
Congress Debates Biosecure Act Amid Report Highlighting Misaligned Foc...
11/18/2024
Chengdu Keymed Licenses BCMAxCD3 Bispecific Antibody to Platina Medici...
11/18/2024
Junshi Biosciences Announces UK MHRA Approval for Marketing of Toripal...
11/18/2024
WuXi AppTec Opens New R&D Center in Changzhou
11/18/2024
IMPACT Thera Raises $34M in Series D++ Funding to Advance PARP Inhibit...
11/18/2024
Merck KGaA and Abbisko's Pimicotinib Shows Promise in Treating Rare Jo...
11/18/2024
ITabMed Unveils Promising Clinical Data on BsAb A-319 for Severe Refra...
11/18/2024
New Report on China's Biopharma Revolution: A Decade of Progress and t...
11/15/2024
NMPA Issues the Interim Rules on Designated Domestic Representatives f...
11/15/2024
Recent Executive Moves
11/14/2024
Lundbeck CEO Optimistic About Vyepti's Market Potential in China Follo...
11/14/2024
Sino Biopharma Gains Chinese Approval for Garsorasib for Advanced NSCL...
11/14/2024
NHC Holds Forum with Domestic and Foreign Pharma Cos on Compliance Iss...
11/14/2024
NHSA Holds Forum on Empowering Commercial Health Insurance with BMI Pl...
11/14/2024
Merck Enters into Global License Deal for LaNova's Anti-PD-1/VEGF BsAb...
11/14/2024
Q3/2024 Performance of Leading MNCs in China: AZ Overtakes MSD as Nova...
11/14/2024
Passage to Asia: Early Access for Innovative Therapies (PharmExec)
11/14/2024
China on the Move: New Level of Opening up in Health Care Sector (NLR)
11/13/2024
How China's Anti-Espionage Law Could Impact Pharmaceutical Supply Chai...
11/13/2024
BioNTech to Acquire Biotheus to Boost Oncology Strategy
11/12/2024
Leman Biotech Raises Over CNY 100M in Series A Funding for CAR-T Thera...
11/12/2024
Shanghai Pharma Eyes Stronger India Partnership for Global Growth
Page:
18
/
359
Total number of articles:
10751
:
[First]
[<<]
[16]
[17]
[18]
[19]
[20]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit